For Esophageal Cancer, Immunotherapy Likely to Play Larger Role

For some people with advanced esophageal cancer, the immunotherapy drugs pembrolizumab (Keytruda) and nivolumab (Opdivo) may become part of early treatment for the disease, according to results from two large clinical trials.

from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/31nS6H8